EGFR Polymorphism and Survival of NSCLC Patients Treated with TKIs: A Systematic Review and Meta-Analysis

Tyrosine kinase inhibitor- (TKI-) based therapy revolutionized the overall survival and the quality of life in non-small-cell lung cancer (NSCLC) patients that have epidermal growth factor receptor (EGFR) mutations. However, EGFR is a highly polymorphic and mutation-prone gene, with over 1200 single...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Oncol
Huvudupphovsmän: Jurisic, Vladimir, Vukovic, Vladimir, Obradovic, Jasmina, Gulyaeva, Lyudmila F., Kushlinskii, Nikolay E., Djordjević, Nataša
Materialtyp: Artigo
Språk:Inglês
Publicerad: Hindawi 2020
Ämnen:
Review Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC7104312/
https://ncbi.nlm.nih.gov/pubmed/32256580
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/1973241
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk